Dr. Jason Andrew Corcoran is a pharmacist who is specialized in Pharmacotherapy in Falls Church, Virginia. Patients can reach him at 3300 Gallows Rd, Falls Church or contact him on 703-776-2293. Active license number of Dr. Jason Andrew Corcoran is 0202206565 for Pharmacotherapy in Virginia. Dr. Jason Andrew Corcoran is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Jason Andrew Corcoran speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Jason Andrew Corcoran are as mentioned below.
NPI Number:
1427257229
NPI Enumeration Date:
12 Jul, 2007
NPI Last Update On:
12 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Jason Andrew Corcoran are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
0202206565
Virginia
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3300 Gallows Rd, Falls Church, Virginia
Zip:
22042-3307
Phone Number:
703-776-2293
Fax Number:
703-776-3035
Patients can reach Dr. Jason Andrew Corcoran at 3300 Gallows Rd, Falls Church, Virginia or can call on phone at 703-776-2293.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.